AU2002364260A1 - Avb3 and avb5 integrin antagonists and methods of treating diseases or conditions associated with avb3 and avb5 integrins - Google Patents

Avb3 and avb5 integrin antagonists and methods of treating diseases or conditions associated with avb3 and avb5 integrins

Info

Publication number: AU2002364260A1
Authority: AU; Australia
Prior art keywords: avb3; avb5; methods; conditions associated; treating diseases
Prior art date: 2001-12-31
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2002364260A

Inventor

Catherine Brennan

Julie Dixon

Jacques Dumas

Barry Hart

Holia Hatoum-Mokdad

Jeffrey Johson

Uday Khire

Peying Liu

Aniko Redman

William J. Scott

Robert Sibley

Jill Wood

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Bayer Pharmaceuticals Corp

Original Assignee

Bayer AG

Bayer Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-12-31

Filing date

2002-12-31

Publication date

2003-07-30

2002-12-31 Application filed by Bayer AG, Bayer Corp filed Critical Bayer AG

2003-07-30 Publication of AU2002364260A1 publication Critical patent/AU2002364260A1/en

Status Abandoned legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C335/04—Derivatives of thiourea
- C07C335/16—Derivatives of thiourea having nitrogen atoms of thiourea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C335/18—Derivatives of thiourea having nitrogen atoms of thiourea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/04—Systems containing only non-condensed rings with a four-membered ring

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

AU2002364260A 2001-12-31 2002-12-31 Avb3 and avb5 integrin antagonists and methods of treating diseases or conditions associated with avb3 and avb5 integrins Abandoned AU2002364260A1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US34572601P	2001-12-31	2001-12-31
US60/345,726		2001-12-31
PCT/US2002/041692 WO2003059872A1 (en)	2001-12-31	2002-12-31	Avb3 and avb5 integrin antagonists and methods of treating diseases or conditions associated with avb3 and avb5 integrins

Publications (1)

Publication Number	Publication Date
AU2002364260A1 true AU2002364260A1 (en)	2003-07-30

Family

ID=23356231

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2002364260A Abandoned AU2002364260A1 (en)	2001-12-31	2002-12-31	Avb3 and avb5 integrin antagonists and methods of treating diseases or conditions associated with avb3 and avb5 integrins

Country Status (2)

Country	Link
AU (1)	AU2002364260A1 (en)
WO (1)	WO2003059872A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR100697612B1 (en) *	2001-07-27	2007-03-22	주식회사유한양행	4-phenyl-3-cyclobutene-1,2-dione derivative and preparation method thereof
GB0406378D0 (en) *	2004-03-22	2004-04-21	Karobio Ab	Novel pharmaceutical compositions
US8076516B2 (en)	2007-11-01	2011-12-13	Acucela, Inc.	Amine derivative compounds for treating ophthalmic diseases and disorders
TWI486326B (en)	2008-10-22	2015-06-01	Acucela Inc	Nitrogen-linked compounds for treating ophthalmic diseases and disorders
SG10201400957UA (en)	2009-03-25	2014-09-26	Abbott Lab	Antiviral Compounds And Uses Thereof
EP2611777B1 (en)	2010-09-03	2016-05-11	Forma TM, LLC.	N-(4-{[pyridin-3-yl-methyl)carbamoyl]amino}benzene-sulfone derivatives as nampt inhibitors for therapy of diseases such as cancer
US10005838B2 (en)	2013-07-19	2018-06-26	The Regents Of The University Of California	Milk fat globule epidermal growth factor 8 regulates fatty acid uptake
CN110128299B (en) *	2019-05-13	2020-11-10	浙江大学	Diphenylurea antitumor small-molecule inhibitor and preparation method thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DK0889876T3 (en) *	1996-03-29	2001-09-24	Searle & Co	Meta-substituted phenylene sulfonamide derivatives

2002
- 2002-12-31 AU AU2002364260A patent/AU2002364260A1/en not_active Abandoned
- 2002-12-31 WO PCT/US2002/041692 patent/WO2003059872A1/en not_active Ceased

Also Published As

Publication number	Publication date
WO2003059872A1 (en)	2003-07-24

Similar Documents

Publication	Publication Date	Title
IL164784A0 (en)	2005-12-18	Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases
DE60230868D1 (en)	2009-03-05	CRIPTOBLOCKING ANTIBODIES AND THEIR USE
PL381765A1 (en)	2007-07-09	Fixing constructions and the method of their application
GB2420630B (en)	2007-03-07	Triboelectric, ranging, or dual use security sensor cable and method of manufacturing same
EP1487492A4 (en)	2008-10-01	The prevention or treatment of cancer using integrin alphavbeta3 antagonists in combination with other agents
ID22619A (en)	1999-12-02	ONCE USE OF MATERIALS FOR THE BODY'S FILTH AND THE PRODUCTION METHOD
EP1501545A4 (en)	2006-08-09	USE OF TNFALPHA ANTIBODIES AND OTHER MEDICINAL PRODUCTS
AU2002360400A8 (en)	2003-06-10	Construction and use of micro-electrode arrays
NZ513680A (en)	2001-09-28	Epitodes or mimotopes derived from the c-epsilon-3 or c-epsilon-4 domains of IgE, antagonists thereof, and their therapeutic uses
FI20012426A0 (en)	2001-12-10	Composite nonwoven, its use and the method of making it
HUP0401605A3 (en)	2012-09-28	Integrin inhibitors for the treatment of eye diseases
ITBO20020487A0 (en)	2002-07-25	CONTAINER AND METHOD FOR THE CREATION OF THE SAME
ITMO20030070A0 (en)	2003-03-14	IMPROVED SNAP HINGE FOR CLOSING ELEMENTS OF COMPARTMENTS AND SIMILAR.
AU2002364260A1 (en)	2003-07-30	Avb3 and avb5 integrin antagonists and methods of treating diseases or conditions associated with avb3 and avb5 integrins
FI20020624A7 (en)	2003-10-03	Titanium dioxide-containing photocatalyst, method of preparation thereof and use thereof
EP1403369A4 (en)	2005-06-15	Method of evaluating the function of phagocyte and utilization thereof
IL161084A0 (en)	2004-08-31	Preparation process of some halogeno-substituted monosulfides and their hydroxy-monosulfide or isothiouronium bromide equivalents as intermediates
AU2002251999A1 (en)	2002-09-12	Methods and compositions for the construction and use of fusion libraries using computational protein design methods
IL145024A0 (en)	2002-06-30	Epitopes or mimotopes derived from the c-epsilon-2 domain of ige, antagonists thereof, and their therapeutic uses
AU2001225372A1 (en)	2001-07-31	Bicyclic heteroaryl compounds as inhibitors of the interaction between the integrin alpha4beta1 receptor and vcam-1 and/or fibronectin
DE60011801D1 (en)	2004-07-29	BENZOXA AND BENZTHIAZOLYL SULFAMATE AND THEIR USE AS STEROID-SULFATASE INHIBITORS
EP1612438A4 (en)	2007-08-29	Constant velocity joint and method of manufacturing the same
DE60201366D1 (en)	2004-11-04	Derivatives of stilbenamine and electrophotosensitive material using the same
AU2003279889A8 (en)	2004-05-04	Electromagnetic wave trasmitter systems, methods and articles of manufacture
AU2003228597A8 (en)	2003-11-03	Antibodies for enzymes of the omega-oxidation pathway and methods relating thereto

Legal Events

Date	Code	Title	Description
2004-09-16	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase